Centersquare Investment Management LLC Has $502.31 Million Stake in Ventas, Inc. $VTR

Centersquare Investment Management LLC lifted its holdings in shares of Ventas, Inc. (NYSE:VTR) by 0.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,491,417 shares of the real estate investment trust’s stock after acquiring an additional 7,300 shares during the period. Ventas makes up 5.0% of Centersquare Investment Management LLC’s holdings, making the stock its 5th biggest holding. Centersquare Investment Management LLC’s holdings in Ventas were worth $502,306,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. increased its position in shares of Ventas by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after acquiring an additional 2,349,176 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Ventas by 1.3% during the third quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock worth $2,078,794,000 after acquiring an additional 387,495 shares in the last quarter. State Street Corp increased its position in shares of Ventas by 3.3% during the third quarter. State Street Corp now owns 28,927,015 shares of the real estate investment trust’s stock worth $2,038,176,000 after acquiring an additional 928,386 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Ventas by 3.8% during the fourth quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after acquiring an additional 475,633 shares in the last quarter. Finally, Capital World Investors bought a new stake in shares of Ventas during the fourth quarter worth about $594,116,000. 94.18% of the stock is owned by institutional investors.

Ventas Stock Down 0.8%

Ventas stock opened at $83.69 on Friday. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $91.06. The stock has a market cap of $40.69 billion, a PE ratio of 152.17, a price-to-earnings-growth ratio of 1.81 and a beta of 0.71. The firm’s 50-day simple moving average is $85.10 and its 200 day simple moving average is $82.47. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25.

Ventas (NYSE:VTR) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the firm posted $0.84 earnings per share. The firm’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Research analysts predict that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s payout ratio is presently 378.18%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on VTR shares. JPMorgan Chase & Co. boosted their target price on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. UBS Group boosted their target price on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Royal Bank Of Canada boosted their target price on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Wells Fargo & Company boosted their price target on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Finally, Jefferies Financial Group boosted their price target on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.19.

Insider Transactions at Ventas

In related news, Director Michael J. Embler bought 2,500 shares of the company’s stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by insiders.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.